Published 2 days ago • loading... • Updated 2 days ago
SEEGNAL INC. ANNOUNCES FILING OF 2025 ANNUAL FILINGS AND THAT THE MCTO WILL NO LONGER BE IN EFFECT AS OF MAY 16, 2026
Seegnal said it filed audited 2025 results and related disclosures, allowing the management cease trade order to end.
On Saturday, Seegnal Inc. announced that the management cease trade order is no longer in effect as of May 16, 2026, following the Company's filing of audited 2025 financial statements on Wednesday, May 13, 2026.
The Alberta Securities Commission issued the MCTO on May 8, 2026, at the Company's request to restrict trading by the Chief Executive Officer and Chief Financial Officer while financial statements were prepared.
Seegnal provides a SaaS-based Clinical Decision Support system integrating patient data including ECG and lab results, reducing clinician alert loads by over 90% while achieving up to 98% accuracy in safety alerts.
The platform serves as a 'standard of care' system for over 10,000 clinicians in Israel, where the Ministry recently adopted it for governmental hospitals. Seegnal also markets the platform in Poland, the UAE, the United Kingdom, and the United States.
Seegnal confirms it remains current with continuous disclosure obligations and anticipates meeting future filing requirements. Operations continue expanding its patient-centric standard across international markets as part of Forward-looking growth initiatives.